US-headquartered pharmacy chain CVS Health has promoted its corporate development and venture investing team’s senior director, Gregor Kevrekian, to executive director.
Kevrekian was a senior director at medical insurance provider Aetna for almost three years, moving to the same position at CVS when it acquired Aetna for $78bn in November 2018.
His role at Aetna involved Kevrekian leading mergers and acquisitions, divestitures and joint venture deals on its behalf, and conducting early-stage investments through its corporate venturing unit, Aetna Ventures.
Deals overseen by Kevrekian at Aetna Ventures included a $36.6m round for behavioural health platform developer AbleTo in 2017 and series A, B and C rounds for cybersecurity software developer CyberGRX.
Kevrekian also helped Aetna sell its Group Life & Disability subsidiary to investment and insurance group The Hartford for $1.45bn in November 2017, and its prescription drug scheme, Standalone Medicare Part D plan, to US government-backed care services provider WellCare in December 2018.
Photo of Gregor Kevrekian courtesy of LinkedIn.
